Free Republic

Israel’s “precision medicine” for COVID-19, which tackles the immune overreaction that causes deterioration from the disease, will start a second round of clinical trials in Greece next week. The testing comes with interest in coronavirus drugs sky-high, amid spiraling cases in several countries where widespread vaccine protection isn’t expected anytime soon, including India, where there are more than 300,000 new cases per day, and Nepal, where hospitals are struggling. The inhaled drug EXO-CD24 was given to 30 patients in moderate condition or worse, and all of them recovered, 29 of them within three to five days. In February Tel Aviv’s...

An Australian drug known as Ivermectin, which is already in use throughout the world to treat parasitic conditions, is showing great results in killing coronavirus in studies involving patients, (according to Sky News.)"Because I'm involved in developing these in the U.S. where all the patients are, there are a number of studies that are amazingly successful. We're talking close to 100%. In fact, we haven't seen a result yet under 100%. It looks like corona is very simple to kill," Professor Thomas Borody, medical director of Australia's Center for Digestive Disease. "It's available as a prescription medication. You wouldn't use...

A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus. The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say. The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus. It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth. Had the drug had been used to treat patients in the UK from the start of the pandemic, up to 5,000...

A cheap steroid called dexamethasone has been found to reduce the risk of death by up to one-third among coronavirus patients with severe respiratory complications, University of Oxford researchers have said.

 Report begins at 1:06.Starts at 1:47 actually.Doxycycline and Ivermectin.Antibiotic and antifungal,100% cure of 60 patients.1-4 cents per pill. https://youtu.be/bU_is2lHfVk  

Tiny biotech company Sorrento Therapeutics (SRNE) claimed Friday its experimental coronavirus treatment is a cure for Covid-19. Meanwhile, another company said it gained authorization for a coronavirus test. In preclinical testing, Sorrento's antibody drug provided "100% inhibition" of SARS-CoV-2 — the new coronavirus that causes Covid-19 — within four days. Sorrento expects this antibody to be the first in a drug cocktail that would create a "protective shield" against infection. "Our STI-1499 antibody shows exceptional therapeutic potential and could potentially save lives following receipt of necessary approvals," Chief Executive Henry Ji said in a written statement. "We at Sorrento are...

The first step in the bioactivation of GS-441524 is the rate-limiting step, something that remdesivir was designed to avoid. But that doesn’t matter clinically because of remdesivir’s rapid transformation to GS-441524 in the bloodstream. Remdesivir’s lackluster results in patients with advanced Covid-19 in the NIAID-sponsored trial and the finding that it provided no statistically significant benefit in a clinical trial conducted in China among patients with severe Covid-19 symptoms are likely due to the suboptimal level of active GS-441524 triphosphate in the lungs. Patients with advanced or severe Covid-19 generally have a high viral load in their lungs and would...

KEY POINTS * Treatment options for critically ill COVID-19 patients treated outside ICUs- need of the hour * A recent study demonstrated that arthritis drug anakinra appeared promising * The U.S.FDA approved arthritis drug found to be safe and effective in treating ARDS

TUSCON, Ariz., April 28, 2020 (GLOBE NEWSWIRE) -- In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®). To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, writes AAPS, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11...

Remdesivir is widely considered to be a front-runner among the investigational therapies being tested as treatments for COVID-19 Gilead Sciences Inc. (GILD) said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study. The early findings set the stage for the closely watched drug to move toward a possible emergency use authorization or approval from the U.S. Food and Drug Administration. The drug is currently being used on an expanded use or compassionate use basis. Shares of Gilead...

Gilead Sciences said Wednesday it is aware of “positive data” from one of its studies looking at antiviral drug remdesivir as a potential treatment for the coronavirus.

Gilead antiviral drug remdesivir flops in first trial Exclusive: Disappointing results revealed in draft documents published accidentally by WHO

Signs are mounting that Gilead’s (NASDAQ:GILD) remdesivir is at least somewhat effective in treating the novel coronavirus. Those signs are positive for the world, and for GILD stock. On April 3, the European Medicines Agency (EMA), the European Union’s equivalent of the U.S. Food and Drug Administration, recommended that remdesivir be approved for compassionate use.According to the EMA, “These [compassionate use] programmes are only put in place if the medicine is expected to help patients with life-threatening, long-lasting or seriously debilitating illnesses, which cannot be treated satisfactorily with any currently authorised medicine.”The agency reported that remdesivir is active against the novel...

Nafamostat mesylate (brand name: Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19). The University of Tokyo announced these new findings on March 18, 2020. According to the new research, Nafamostat can prevent the fusion of the envelope of the virus with host cell surface membranes, the first step in infection with the causative virus SARS-CoV-2. Nafamostat can inhibit the membrane fusion at a concentration less than one-tenth that of Camostat mesylate (brand name: Foypan)

President Trump said the drug has shown 'very, very encouraging early results' Pharmaceutical company Bayer has responded to the ongoing outbreak of the Wuhan coronavirus — formally known as COVID-19 — by donating millions of tablets of an anti-malarial drug that could be used to combat the disease to the United States government. Ditch the fake news ==> Click here to get news you can trust sent right to your inbox. It's free! According to a story published Thursday at MarketWatch: U.S. listed shares of Bayer AG bayry rose 3% in trading on Thursday afternoon after it said it had...

A US biotech firm has ramped up production of an experimental drug that has become a focal point for hopes of an effective treatment for coronavirus. The first clinical trial of the antiviral medicine remdesivir in Covid-19 patients is due to report its findings next month according to Gilead Sciences, which said it had accelerated manufacturing of the drug to increase its supplies “as rapidly as possible”. As the coronavirus outbreak has unfolded, about 300 separate trials into different drugs and experimental therapies have been launched in the absence of any established treatments. Many see remdesivir, originally developed to treat...